Recent news on Micafungin

Micafungin Effective for Serious Candida Infections  -  Apr 26, 2007
MedPage Today,Explain that this study concludes that micafungin (Mycamine) is as effective as liposomal amphotericin B (Ambisome) in treating these serious infections,

Mycamine™ Equivalent to Ambisome® with Less Side Effects for ...  -  May 9, 2007
Cancer Consultants (press release),An international randomized trial has demonstrated that Mycamine (micafungin) is equivalent to Ambisome (liposomal amphotericin B) for the treatment of

Astellas Drug Is Less Risky Than Older Antifungal, Lancet Says  -  Apr 25, 2007
BloombergApril 26 (Bloomberg) -- Astellas Pharma Inc.'s micafungin is as effective as the company's AmBisome treatment in fighting certain fungal infections,

New Treatment for Serious Candida Infections  -  Apr 26, 2007
Insider Medicine,In this study, researchers tested the effectiveness of two drugs: liposomal amphotericin B and micafungin, to treat common, but potentially life-threatening

New treatment targets thrush  -  Apr 26, 2007
InTheNews.co.uk,The drug – micafungin – was found to work as well as liposomal amphotericin B and caused fewer side effects, scientists report today in the online edition

Astellas and Daiichi Sankyo figures fail to dazzle  -  May 16, 2007
Pharma Times (subscription),Vesicare (solifenacin) for overactive bladder leapt 144.3% to 36.2 billion yen while the antifungal agent Funguard/Mycamine (micafungin) had sales of 16.5

Micafungin Effective for Serious Candida Infections  -  26 Apr 2007
MedPage Today,Explain that this study concludes that micafungin (Mycamine) is as effective as liposomal amphotericin B (Ambisome) in treating these serious infections,

New treatment targets thrush  -  26 Apr 2007
InTheNews.co.uk,The drug – micafungin – was found to work as well as liposomal amphotericin B and caused fewer side effects, scientists report today in the online edition

New treatment Candida fungi - fewer side effects  -  26 Apr 2007
News-Medical.net,A total of 531 patients with these infections were split into two groups and given either micafungin 100mg per day or liposomal amphotericin B 3mg per kg

Astellas Drug Is Less Risky Than Older Antifungal, Lancet Says  -  26 Apr 2007
BloombergApril 26 (Bloomberg) -- Astellas Pharma Inc.'s micafungin is as effective as the company's AmBisome treatment in fighting certain fungal infections,

Data on Telavancin and Micafungin Hold Promise of New Therapeutic ...  -  Apr 2, 2007
PR Newswire (press release),Micafungin data presented show that micafungin demonstrates broad-spectrum efficacy against Candida infections.(8) More specifically data showed that in

Micafungin as Effective as Liposomal Amphotericin B in Children ...  -  Apr 2, 2007
DG NewsHowever, the researchers report, micafungin treatment showed a tendency to fewer treatment-related adverse events, and near significance for fewer

Data on Telavancin and Micafungin Hold Promise of New Therapeutic ...  -  Apr 2, 2007
PR Newswire (press release),Micafungin data Micafungin data presented show that micafungin demonstrates broad-spectrum efficacy against Candida infections.(8) More specifically data

Mitsubishi/Tanabe merger may be first of many in Japan  -  Feb 5, 2007
Pharma Times (subscription),North American sales were up 1.6% to 128.5 thanks to Prograf, Vesicare, the antifungal agent Mycamine (micafungin) and Amevive (alefacept) for psoriasis,

Astellas Pharma US, Inc. Announces Availability of Mycamine(R ...  -  Jan 12, 2007
DG NewsDEERFIELD, IL -- January 12, 2007 -- Astellas Pharma US, Inc. announced today the availability of their antifungal agent Mycamine(R) (micafungin sodium) for

Astellas terminates development of heart failure drug in US  -  Jan 12, 2007
Pharma Times (subscription),...seeking approval for the use of its antifungal agent Mycamine (micafungin) for injection in the treatment of candidemia and other candida infections.

Astellas Pharma US, Inc. Submits Supplemental New Drug Application ...  -  Dec 27, 2006
PharmaLive.com (press release),MYCAMINE (micafungin sodium) for injection is an echinocandin -- a newer class of antifungal agents. MYCAMINE inhibits an enzyme essential for fungal

Astellas Pharma US, Inc. Submits Supplemental New Drug Application ...  -  Dec 26, 2006
PR Newswire (press release),1) About MYCAMINE MYCAMINE (micafungin sodium) for injection is an echinocandin -- a newer class of antifungal agents. MYCAMINE inhibits an enzyme essential

100mg Vial  -  Jan 16, 2007
Pharmaceutical Processing,Astellas Pharma US, Inc. has announced the availability of their antifungal agent MYCAMINE® (micafungin sodium) for injection in a 100mg vial format.

Astellas Pharma US, Inc. Announces Availability of MYCAMINE(R ...  -  Jan 15, 2007
Drug Newswire (press release),12 /PRNewswire/ -- Astellas Pharma US, Inc. announced today the availability of their antifungal agent MYCAMINE(R) (micafungin sodium) for injection in a

Astellas Pharma US, Inc. Announces Availability Of MYCAMINE(R ...  -  Jan 13, 2007
Medical News Today (press release),Astellas Pharma US, Inc. announced today the availability of their antifungal agent MYCAMINE(R) (micafungin sodium) for injection in a 100mg vial format.

Source: Astellas Pharma US, Inc.  -  26 Dec 2006
Yahoo! News (press release)MYCAMINE (micafungin sodium) for injection is an echinocandin -- a newer class of antifungal agents. MYCAMINE inhibits an enzyme essential for fungal

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional